PT Siloam International Hospitals Tbk (SILO.JK)
IDR 2950.0
(-2.64%)
IDR 2950.0
(-2.64%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3644.9 Billion IDR | 3.16% |
| 2022 | 3533.38 Billion IDR | -2.31% |
| 2021 | 3616.94 Billion IDR | 55.17% |
| 2020 | 2330.93 Billion IDR | 5.96% |
| 2019 | 2199.89 Billion IDR | 14.05% |
| 2018 | 1928.85 Billion IDR | 16.82% |
| 2017 | 1651.12 Billion IDR | 8.47% |
| 2016 | 1522.16 Billion IDR | 29.38% |
| 2015 | 1176.54 Billion IDR | 23.58% |
| 2014 | 952.06 Billion IDR | 44.54% |
| 2013 | 658.69 Billion IDR | 48.08% |
| 2012 | 444.81 Billion IDR | 33.34% |
| 2011 | 333.58 Billion IDR | 29.52% |
| 2010 | 257.55 Billion IDR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 1250.7 Billion IDR | 26.26% |
| 2024 Q2 | 990.57 Billion IDR | 5.14% |
| 2024 Q1 | 942.16 Billion IDR | -7.89% |
| 2023 Q3 | 1218.57 Billion IDR | 22.15% |
| 2023 Q2 | 997.62 Billion IDR | -1.66% |
| 2023 Q1 | 1014.46 Billion IDR | -2.74% |
| 2023 FY | 3644.9 Billion IDR | 3.16% |
| 2023 Q4 | 1022.88 Billion IDR | -16.06% |
| 2022 FY | 3533.38 Billion IDR | -2.31% |
| 2022 Q4 | 1043.01 Billion IDR | 5.5% |
| 2022 Q3 | 988.68 Billion IDR | 35.24% |
| 2022 Q2 | 731.07 Billion IDR | -5.13% |
| 2022 Q1 | 770.61 Billion IDR | -9.41% |
| 2021 Q4 | 850.65 Billion IDR | -13.01% |
| 2021 Q2 | 880.6 Billion IDR | -3.0% |
| 2021 Q3 | 977.87 Billion IDR | 11.05% |
| 2021 FY | 3616.94 Billion IDR | 55.17% |
| 2021 Q1 | 907.8 Billion IDR | 20.36% |
| 2020 FY | 2330.93 Billion IDR | 5.96% |
| 2020 Q2 | 327.47 Billion IDR | -47.93% |
| 2020 Q1 | 628.93 Billion IDR | 30.04% |
| 2020 Q4 | 754.24 Billion IDR | 21.6% |
| 2020 Q3 | 620.28 Billion IDR | 89.42% |
| 2019 FY | 2199.89 Billion IDR | 14.05% |
| 2019 Q3 | 619.31 Billion IDR | 15.86% |
| 2019 Q2 | 534.54 Billion IDR | -4.95% |
| 2019 Q4 | 483.66 Billion IDR | -21.9% |
| 2019 Q1 | 562.37 Billion IDR | 7.35% |
| 2018 Q3 | 536.23 Billion IDR | 27.19% |
| 2018 Q4 | 523.88 Billion IDR | -2.3% |
| 2018 FY | 1928.85 Billion IDR | 16.82% |
| 2018 Q1 | 447.12 Billion IDR | 11.25% |
| 2018 Q2 | 421.61 Billion IDR | -5.71% |
| 2017 FY | 1651.12 Billion IDR | 8.47% |
| 2017 Q3 | 479.58 Billion IDR | 28.97% |
| 2017 Q1 | 397.78 Billion IDR | -0.68% |
| 2017 Q4 | 401.89 Billion IDR | -16.2% |
| 2017 Q2 | 371.84 Billion IDR | -6.52% |
| 2016 Q3 | 355.72 Billion IDR | -9.1% |
| 2016 FY | 1522.16 Billion IDR | 29.38% |
| 2016 Q2 | 391.32 Billion IDR | 4.47% |
| 2016 Q1 | 374.57 Billion IDR | 17.03% |
| 2016 Q4 | 400.53 Billion IDR | 12.6% |
| 2015 Q1 | 306.95 Billion IDR | 7.75% |
| 2015 Q2 | 259.11 Billion IDR | -15.58% |
| 2015 FY | 1176.54 Billion IDR | 23.58% |
| 2015 Q4 | 320.07 Billion IDR | 10.22% |
| 2015 Q3 | 290.39 Billion IDR | 12.07% |
| 2014 Q3 | 235.57 Billion IDR | 7.88% |
| 2014 Q2 | 218.35 Billion IDR | 2.39% |
| 2014 Q1 | 213.24 Billion IDR | 7.12% |
| 2014 FY | 952.06 Billion IDR | 44.54% |
| 2014 Q4 | 284.89 Billion IDR | 20.94% |
| 2013 Q4 | 199.07 Billion IDR | 41.94% |
| 2013 Q1 | 161.64 Billion IDR | 28.96% |
| 2013 FY | 658.69 Billion IDR | 48.08% |
| 2013 Q2 | 157.72 Billion IDR | -2.42% |
| 2013 Q3 | 140.25 Billion IDR | -11.08% |
| 2012 Q4 | 125.34 Billion IDR | 0.0% |
| 2012 FY | 444.81 Billion IDR | 33.34% |
| 2011 FY | 333.58 Billion IDR | 29.52% |
| 2010 FY | 257.55 Billion IDR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| PT Bundamedik Tbk | 582.25 Billion IDR | -525.994% |
| PT Metro Healthcare Indonesia Tbk | 89.65 Billion IDR | -3965.512% |
| PT Medikaloka Hermina Tbk | 1824.23 Billion IDR | -99.804% |
| PT Mitra Keluarga Karyasehat Tbk | 1968.05 Billion IDR | -85.204% |
| PT Murni Sadar Tbk | 167.6 Billion IDR | -2074.704% |
| PT Famon Awal Bros Sedaya Tbk | 515.99 Billion IDR | -606.389% |
| PT Royal Prima Tbk | 75.23 Billion IDR | -4744.603% |
| PT Kedoya Adyaraya Tbk | 128.11 Billion IDR | -2745.084% |
| PT Sarana Meditama Metropolitan Tbk | 434.04 Billion IDR | -739.757% |
| PT Sejahteraraya Anugrahjaya Tbk | 718.02 Billion IDR | -407.633% |